COX-2 Inhibitors as Adjunctive Therapy in Schizophrenia: Rationale for Use and Evidence to Date

ISSN： 1172-7047

Source： CNS Drugs, Vol.19, Iss.10, 2005-01, pp. : 805-819

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COX-2 inhibitors as adjunctive therapy in schizophrenia

By Müller Norbert Strassnig Martin Schwarz Markus J Ulmschneider Markus Riedel Michael

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 1033-1044

Informa Healthcare

Access to resources Recommend Favorite

Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?

By Benzi G. Moretti A.

European Journal of Pharmacology, Vol. 346, Iss. 1, 1998-04 ,pp. : 1-13

Elsevier

Access to resources Recommend Favorite

Cholinesterase Inhibitors as Adjunctive Therapy in Patients with Schizophrenia and Schizoaffective Disorder: A Review and Meta-Analysis of the Literature

By Ribeiz Salma R.I.

CNS Drugs, Vol. 24, Iss. 4, 2010-04 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

Back to the Future: COX-2 Inhibitors for Chemoprevention and Cancer Therapy

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 6, 2007-06 ,pp. : 599-608

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. : 1465-1468

Informa Healthcare

Access to resources Recommend Favorite